Related Experiment Video
Updated: Jun 19, 2026

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons
Published on: May 25, 2015
The pragmatic use of apomorphine at the end of life
1Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK. drfelicitywerrett@doctors.org.uk
Abstract:
Parkinson's Disease (PD) is an irreversible degenerative neurological disorder with no known cure. Apomorphine is a potent short-acting D1/D2 dopamine agonist administered sub-cutaneously that is used in the treatment of PD. Optimising PD medication is an important aspect of end of life care. There are no previously reported cases of apomorphine providing symptom relief in terminal care of PD patients. This case highlights its potential benefits for symptom control at the end of life.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Ethical Dilemmas II
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Ethical Issues
Ethical Concerns in Healthcare:

